Manuela A. Joore

Manuela A. Joore publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Manuela A. Joore sits on this spectrum.

Manuela A. Joore D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Manuela A. Joore sits on this spectrum.

Best Publications

• Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis

  M. Westwood;M. Joore;J.P.C. Grutters;K. Redekop

  268
  Citations

• How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons

  Andrea Peeters;Janneke P.C. Grutters;Madelon Pijls-Johannesma;Stefan Reimoser

  265
  Citations

• High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis

  Marie Westwood;Thea van Asselt;Bram Ramaekers;Penny F Whiting

  229
  Citations

• GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

  Jan L Brozek;Carlos Canelo-Aybar;Elie A Akl;James M Bowen

  224
  Citations

• Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.

  M P Rutten-van Mölken;Maarten Postma;M A Joore;M L Van Genugten

  194
  Citations

• Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

  Marie Westwood;Manuela Joore;Penny F Whiting;Thea van Asselt

  191
  Citations

• Tinnitus: a cost study.

  Iris H. L. Maes;Rilana F. F. Cima;Johannes W. Vlaeyen;Lucien J. C. Anteunis

  186
  Citations

• Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.

  Marie Westwood;Bram Ramaekers;Penny Whiting;Florian Tomini

  151
  Citations

• Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.

  Marie Westwood;Bram Ramaekers;Shona Lang;Sabine Grimm

  148
  Citations

• Joint recovery programme versus usual care: an economic evaluation of a clinical pathway for joint replacement surgery.

  Daniëlle E Brunenberg;Mike J van Steyn;Judith C Sluimer;Linda L Bekebrede

  144
  Citations

• Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints

  Janneke P. C. Grutters;Manuela A. Joore;Frans van der Horst;Hans Verschuure

  135
  Citations

• Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer

  Valesca P. Retèl;Manuela A. Joore;Michael Knauer;Sabine C. Linn

  116
  Citations

• Health-related quality of life in patients surviving non-small cell lung cancer

  Janneke P C Grutters;Manuela A Joore;Erwin M Wiegman;Johannes A Langendijk

  114
  Citations

• Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children.

  Lisa C. Martial;Rob E. Aarnoutse;Michiel F. Schreuder;Stefanie S. Henriet

  113
  Citations

• The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.

  Janneke P.C. Grutters;Madelon Pijls-Johannesma;Dirk De Ruysscher;Andrea Peeters

  97
  Citations

• Response shift in the measurement of quality of life in hearing impaired adults after hearing aid fitting.

  M.A. Joore;J. Potjewijd;A.A. Timmerman;L.J.C. Anteunis

  97
  Citations

• The Impact of Differences in EQ-5D and SF-6D Utility Scores on the Acceptability of Cost–Utility Ratios: Results across Five Trial-Based Cost–Utility Studies

  Manuela A Joore;Danielle Brunenberg;Patricia Nelemans;Emiel Wouters

  96
  Citations

• Acknowledging Patient Heterogeneity in Economic Evaluation A Systematic Literature Review

  Janneke P. C. Grutters;Mark Sculpher;Andrew H. Briggs;Johan L. Severens

  91
  Citations

• Willingness to Accept versus Willingness to Pay in a Discrete Choice Experiment

  Janneke P.C. Grutters;Alfons G.H. Kessels;Carmen D. Dirksen;Debby van Helvoort-Postulart

  91
  Citations

• Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder.

  Randall K. Leong;Stephan G. G. de Wachter;Manuela A. Joore;Philip E. V. A. Van Kerrebroeck

  89
  Citations